Interestingly, C220 partially reduced the expression of global H4R3me2s (Fig. 2E), which has been reported as one mechanism of a PRMT5-mediated DNA damage response in prostate cancer (14). The gene discussed is PRMT5; the disease is prostate carcinoma.